在费城样急性淋巴细胞白血病中，一刀切的方法并不适用。
One size doesn't fit all in Ph-like ALL.
作者信息
Post Sean M
机构信息
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER.
出版信息
Blood. 2017 Jan 12;129(2):140-141. doi: 10.1182/blood-2016-11-749168.
Abstract
In this issue of , Tasian et al provide compelling evidence that tailored therapies are an effective strategy in treating genetically defined Philadelphia chromosome–like (Ph-like) acute lymphoblastic leukemia (ALL).
摘要
在本期《 》中，塔西安等人提供了令人信服的证据，表明针对特定基因特征的疗法是治疗基因定义的费城染色体样（Ph样）急性淋巴细胞白血病（ALL）的有效策略。
相似文献
1
One size doesn't fit all in Ph-like ALL.在费城样急性淋巴细胞白血病中，一刀切的方法并不适用。
Blood. 2017 Jan 12;129(2):140-141. doi: 10.1182/blood-2016-11-749168.
2
"It just doesn't matter, it just doesn't matter, it just doesn't matter,...".“这根本不重要，这根本不重要，这根本不重要，……”
PDA J Pharm Sci Technol. 1998 Jul-Aug;52(4):149-50.
3
Reply: AKI Classification: One Size Doesn't Fit All.
J Cardiothorac Vasc Anesth. 2016 Aug;30(4):e36-7. doi: 10.1053/j.jvca.2016.01.028. Epub 2016 Jan 28.
4
Commentary: One size doesn't always fit all.评论：一刀切并不总是适用。
J Thorac Cardiovasc Surg. 2020 Jul;160(1):180-181. doi: 10.1016/j.jtcvs.2019.12.093. Epub 2020 Jan 11.
5
Anticoagulation for atrial fibrillation in children; one size doesn't fit all!儿童心房颤动的抗凝治疗；并非一概而论！
Ann Pediatr Cardiol. 2020 Oct-Dec;13(4):375-376. doi: 10.4103/apc.APC_122_20. Epub 2020 Sep 17.
6
One size doesn't fit all.一种尺寸并不适合所有人。
Microbiology (Reading). 2006 Jul;152(Pt 7):1891. doi: 10.1099/mic.0.29073-0.
7
Placement of the Double-Lumen Endotracheal Tube: One Size Doesn't Fit All.双腔气管内导管的放置：一种尺寸并不适用于所有人。
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):287-289. doi: 10.1053/j.jvca.2017.09.029. Epub 2017 Sep 21.
8
When One Size Doesn't Fit All.当一种尺寸并不适合所有人时。
P T. 2012 Feb;37(2):69.
9
One Size Doesn't Fit All: Variant-Specific Effects in SCN8A Encephalopathy.一刀切并不适用于所有情况：SCN8A 脑病中的特定变体效应。
Epilepsy Curr. 2021 Mar 16;21(3):183-185. doi: 10.1177/15357597211002206. eCollection 2021 May-Jun.
10
One size doesn't fit all.一种尺码并不适合所有人。
Mult Scler Relat Disord. 2019 Jun;31:A1-A2. doi: 10.1016/j.msard.2019.04.034. Epub 2019 Apr 30.
本文引用的文献
1
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.PI3K/mTOR与JAK或ABL联合抑制在Ph样急性淋巴细胞白血病小鼠异种移植模型中的强效疗效。
Blood. 2017 Jan 12;129(2):177-187. doi: 10.1182/blood-2016-05-707653. Epub 2016 Oct 24.
2
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.成人急性淋巴细胞白血病的病理生理学和治疗新见解。
Cancer. 2015 Aug 1;121(15):2517-28. doi: 10.1002/cncr.29383. Epub 2015 Apr 17.
3
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Ph 样急性淋巴细胞白血病中可靶向的激酶激活病变。
N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088.
4
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.1990 至 2005 年期间儿童及青少年急性淋巴细胞白血病存活率的提高：儿童肿瘤协作组的报告。
J Clin Oncol. 2012 May 10;30(14):1663-9. doi: 10.1200/JCO.2011.37.8018. Epub 2012 Mar 12.
5
mTOR: from growth signal integration to cancer, diabetes and ageing.mTOR：从生长信号整合到癌症、糖尿病和衰老。
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. doi: 10.1038/nrm3025. Epub 2010 Dec 15.
6
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.功能筛选鉴定出前 B 细胞急性淋巴细胞白血病中的 CRLF2。
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):252-7. doi: 10.1073/pnas.0911726107. Epub 2009 Dec 15.
7
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.治疗结果不佳的儿童急性淋巴细胞白血病亚型：一项全基因组分类研究。
Lancet Oncol. 2009 Feb;10(2):125-34. doi: 10.1016/S1470-2045(08)70339-5. Epub 2009 Jan 8.
8
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.在人类癌症中，mTORC1的抑制通过PI3K依赖性反馈环导致MAPK途径激活。
J Clin Invest. 2008 Sep;118(9):3065-74. doi: 10.1172/JCI34739.
Zotero 插件